Corneal wound healing is a complex process that consists of cellular integration of multiple soluble biochemical cues and cellular responses to biophysical attributes associated with the matrix of the wound space. Upon corneal stromal wounding, the transformation of corneal fibroblasts to myofibroblasts is promoted by transforming growth factor-β (TGFβ). This process is critical for wound healing; however, excessive persistence of myofibroblasts in the wound space has been associated with corneal fibrosis resulting in severe vision loss. The objective of this study was to determine the effect of hepatocyte growth factor (HGF), which can modulate TGFβ signaling, on corneal myofibroblast transformation by analyzing the expression of α-smooth muscle actin (αSMA) as a marker of myofibroblast phenotype particularly as it relates to biomechanical cues. Human corneal fibroblasts were cultured on tissue culture plastic (> 1 GPa) or hydrogel substrates mimicking human normal or wounded corneal stiffness (25 and 75 kPa) in media containing TGFβ1 ± HGF. The expression of αSMA was analyzed by quantitative PCR, Western blot and immunocytochemistry. Cellular stiffness, which is correlated with cellular phenotype, was measured by atomic force microscopy (AFM). In primary human corneal fibroblasts, the mRNA expression of αSMA showed a clear dose response to TGFβ1. The expression was significantly suppressed when cells were incubated with 20 ng/ml HGF in the presence of 2 ng/ml of TGFβ1. The protein expression of αSMA induced by 5 ng/ml TGFβ1 was also decreased by 20 ng/ml of HGF. Cells cultured on hydrogels mimicking human normal (25 kPa) and fibrotic (75 kPa) cornea also showed an inhibitory effect of HGF on αSMA expression in the presence or absence of TGFβ1. Cellular stiffness was decreased by HGF in the presence of TGFβ1 as measured by AFM. In this study, we have demonstrated that HGF can suppress the myofibroblast phenotype promoted by TGFβ1 in human corneal stromal cells. These data suggest that HGF holds the potential as a therapeutic agent to improve wound healing outcomes by minimizing corneal fibrosis.
Introduction
Upon corneal stromal injury, quiescent keratocytes differentiate into spindle-shaped fibroblasts which acquire a migratory phenotype through the increased expression of actin. This expression generates traction forces enabling fibroblasts to proliferate and migrate towards the wound, repopulating the region that had been depleted of keratocytes through apoptosis (Moller-Pedersen et al., 1998; Zieske et al., 2001; Hinz et al., 2001) . Upon arrival to the corneal wound bed, fibroblasts differentiate into myofibroblasts that elaborate extracellular matrix (ECM) and generate contractile forces engaged in corneal wound closure (Ishizaki et al., 1993; Petroll et al., 1993; Jester et al., 1995; Kurosaka et al., 1998) . Myofibroblasts are characterized by the expression of α-smooth muscle actin (αSMA) whose expression directly correlates with corneal wound contraction (Jester et al., 1995) . After proper corneal healing, myofibroblasts disappear from the wound space through apoptosis (Wilson et al., 2007) . However, multiple reports document long-term corneal opacity from excessive numbers and/or prolonged persistence of myofibroblasts after healing (Wilson et al., 2001; Ljubimov and Saghizadeh, 2015) . Myofibroblasts are less transparent than keratocytes and produce a disorganized ECM, leading to the development of corneal stromal opacity and fibrosis. The transformation from fibroblasts to myofibroblasts is mainly triggered by transforming growth factor-β (TGFβ) Carrington et al., 2006; Singh et al., 2014) which is a critical cytoactive factor that participates in the signaling cascades that promote corneal scarring. Additionally, we have shown that biophysical cues represent potent modulators of this corneal stromal cell transformation (Myrna et al., 2009 (Myrna et al., , 2012 Pot et al., 2010; Dreier et al., 2013) as well as the response of these cells to therapeutic agents , and cellular elastic modulus was strongly correlated to myofibroblast phenotype, corneal fibrosis and haze formation (Raghunathan et al., 2017) .
Hepatocyte growth factor (HGF) is primarily secreted by mesenchymal cells and stimulates morphogenesis, migration, proliferation and survival of epithelial cells that express its specific receptor (Montesano et al., 1991; Sonnenberg et al., 1993; Matsumoto and Nakamura, 1996; Birchmeier and Gherardi, 1998; Miyagi et al., 2018) . Additionally, HGF is a well-known antifibrotic molecule that counteracts TGFβ to reduce fibrosis in various organs (Dai and Liu, 2004; Mizuno and Nakamura, 2004; Okayama et al., 2012) . HGF inhibits TGFβ production in cultures of myofibroblasts (Mizuno and Nakamura, 2004; Nakamura et al., 2005) and intercepts the TGFβ signaling pathway by inhibiting nuclear Smad2 and Smad3 activation (Dai and Liu, 2004) . Moreover, HGF reduces the TGFβ-receptor (Yang and Liu, 2002) and induces decorin, an inhibitor of TGFβ1 (Kobayashi et al., 2003) , all of which can lead to antifibrotic outcomes in vivo. Additionally, HGF induces urokinase-type plasminogen activator (Pepper et al., 1992) , and matrix metalloprotease in myofibroblasts . These proteases are critical for degradation of ECM and fibronectin, an essential anchor maintaining cell survival. As a result, HGF indirectly promotes myofibroblast apoptosis by decreasing the number of ECM anchors. A growing body of evidence supports the concept that HGF elicits the regression of fibrosis in numerous organs which TGFβ-induced myofibroblasts are implicated as central players in promoting tissue scarring. However, the role of HGF in corneal biology and repair has been understudied . A recent study documented that the administration of HGF can restore corneal transparency after wounding in a murine model (Mittal et al., 2016) .
Therefore, we hypothesized that HGF would modulate fibroblast to myofibroblast transformation promoted by TGFβ1 as well as substrate stiffness.
Materials and methods

Isolation, culture and treatment of primary human corneal fibroblasts
Primary human corneal fibroblasts (HCFs) were isolated from donated human corneoscleral rims unsuitable for transplantation (Heartland Lions Eye Bank, Kansas City, MO). All experiments complied with the Declaration of Helsinki. The cell isolation was performed as previously described (Dreier et al., 2013) with slight modifications. Briefly, corneal epithelial and endothelial cells were removed by gentle debridement of the anterior and posterior surface. Then, a central corneal button was obtained using an 8 mm-diameter biopsy punch (Integra Miltex, York, PA) followed which was then hemisected with a scalpel. The remaining corneal stroma containing keratocytes was incubated in a four-well plate (Nunc, Penfield, NY) filled with Dulbecco's modified Eagle's medium (DMEM) high glucose (HyClone; GE Healthcare) supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals, Lawrenceville, GA) and 1% penicillin-streptomycin-amphotericin B (P/S/F; Life Technologies). In this study, all cell culture media contained serum because the presence of serum is known to cause a transition of quiescent keratocytes to active fibroblasts (Masur et al., 1996; Jester and Ho-Chang, 2003) . Stromal cells were isolated and were expanded up to five passages. Primary HCFs from up to six different donors were isolated and cultured in DMEM high glucose with 10% FBS and 1% P/S/F at 37°C under 5% CO 2 and were utilized between passages two and five. Primary HCFs were plated on six-well plates at a density of 7.5 × 10 4 per well for Quantitative real-time PCR (qPCR), on four-well plates at a density of 2.0 × 10 5 for Western blotting and on coverslips in 24-well plate at a density of 1.0 × 10 4 for immunocytochemistry in culture medium and were left to adhere overnight. To confirm the biological activity of TGFβ and HGF, we treated HCFs grown on tissue culture plastic (TCP) with human recombinant TGFβ1 (T7039; Sigma-Aldrich, St. Louis, MO) and/or human recombinant HGF (R&D Systems, Minneapolis, MN) for 24 h in serumcontaining medium.
Fabrication of compliant polyacrylamide substrates
Polyacrylamide hydrogels were prepared to approximate the stiffness of human normal (25 kPa) and fibrotic cornea (75 kPa) as previously described McKee et al., 2011) . To remove unreacted reagents, the gels were rinsed three times in PBS (HyClone; GE Healthcare, Amersham Place, Little Chalfont, Buckinghamshire HP7 9NA, England) and were sterilized in a hydrated state by exposure to short-wavelength UV light (280 nm) for 30 min. Following another PBS rinse, the gels were stored in a 5% CO 2 incubator at 37°C for 24 h incubation to attain full hydration. Then, the gels were cut into pieces and rinsed six times over at least 72 h. The gels were then allowed to equilibrate in the growth media for 24 h before utilized. Atomic force microscopy (AFM) was used to determine the elastic modulus of hydrogels (Radmacher et al., 1992) .
Cell culture on compliant polyacrylamide substrates
The gels were placed in the culture medium for 24 h to attain equilibrium. Before cell plating, gels were treated for 5 min with a mixture of 97% collagen I and 3% collagen III (PureCol; Advanced Biomatrix, Fremont, CA) diluted in an equal volume of 12 mM HCl (Acros Organics, Geel, Belgium) to achieve a molecular coating of collagen and were subsequently rinsed three times with PBS. The stiffness of the gels was not impacted by the collagen coating as measured by AFM (data not shown). Primary HCFs were plated on gels in four-well plates at a density of 1.5 × 10 5 per well for PCR and 2.0 × 10 5 per well for Western blotting in culture medium and were left to adhere overnight. The following day, the medium was changed with the appropriate medium containing TGFβ1 or HGF. After 24-h incubation, cells were harvested for RNA or proteins.
RNA extraction and quantitative real-time PCR
RNA was extracted 24 h after treatment with TGFβ1 or HGF using GeneJET RNA Purification Kit (Thermo Scientific, Waltham, MA) following the manufacturer's protocol. Quantitative real-time PCR was performed using the SensiFAST Probe Hi-ROX One-Step kit (Bioline, Taunton, MA) and TaqMan aptamers specific to human glyceraldehyde 3-phospate dehydrogenase (GAPDH, Hs99999905; Applied Biosystems, Carlsbad, CA) or αSMA (ACTA2, Hs00426835; Applied Biosystems) in total volume 10 μl per reaction as previously described (Dreier et al., 2013) ; GAPDH expression served as a reference. Each experiment was performed with samples from at least three individuals. Gene expression data were calculated as previously reported , and normalized relative to the expression of mRNA from cells grown on TCP in the absence of TGFβ1 or HGF.
Western blot analysis
Protein was extracted 24 h after the TGFβ1 or HGF treatment using a RIPA buffer and Protease & Phosphatase Inhibitor Cocktail (Thermo Scientific). Equivalent amounts of protein (15 μg) were loaded onto a 10% NuPAGE Bis-Tris gel (Life Technologies, Carlsbad, CA). Gel electrophoresis was performed at 100 mA for 35 min per one gel, followed by transfer to a nitrocellulose membrane (Life Technologies, Carlsbad, CA) at 1.3 A for 10 min. The membrane was blocked at 37°C for 1 h with a blocking buffer containing 80% PBS, 10% FBS, and 10% Superblock (Thermo Scientific). The membrane was incubated with a primary antibody specific to anti-αSMA (A5228; Sigma-Aldrich) diluted 1:100 in a blocking buffer or anti-Transketolase (sc-390179; Santa Cruz Biotechnology) diluted 1:150 in a blocking buffer at 37°C for 1 h. The blot was washed three times in TBS with 0.1% Tween-20 (TBS-T) before incubating with peroxidase-conjugated goat anti-mouse antibody (KPL, Gaithersburg, MD) diluted 1:20,000 in a blocking buffer at 37°C for 1 h. After washing twice with TBS-T and once with TBS, protein bands of interest were detected using Western blotting detection kit (WesternBright Quantum, Advansta, Menlo Park, CA) and ChemiDocIt2 Imaging system (UVP, Upland, CA). The same blots were used for detection of GAPDH (sc-32233; Santa Cruz Biotechnology) diluted 1:150 in blocking buffer as a reference protein. Densitometry analyses were done with ImageJ software (National Institutes of Health, Bethesda, MD). The band densities of αSMA were normalized by the values of GAPDH. Western blot analyses were performed on samples from at least three independent experiments.
Immunocytochemistry and fluorescent microscopy
Cells were fixed with 4% formaldehyde (Polysciences Inc., Warrington, PA) in PBS for 20 min at room temperature and subsequently incubated with 0.3% H 2 O 2 (Sigma-Aldrich) in ice-cold PBS for 30 min at 4°C. Nonspecific binding sites were blocked with blocking buffer (10% FBS/10% Superblock in PBS) for 30 min at 37°C. Then, cells were incubated with primary antibody (mouse anti-αSMA, A5228; Sigma-Aldrich) 1:100 in a blocking buffer for 1 h at 37°C and washed three times in PBS. Incubation with secondary antibody (goat antimouse IgG, AlexaFluor 488; Life Technologies) 1:250 in a blocking buffer for 30 min at 37°C was followed by three washes in PBS. Nuclei were stained for 10 min at 37°C with 4′,6-diamidino-2-phenylindole (DAPI; BioGenex, San Ramon, CA) 1:10,000 in PBS. Cells were imaged in Mowiol (Sigma-Aldrich) with × 20 objective using the Axiovert 200 M microscope (Carl Zeiss, Jena, Germany).
Atomic force microscopy on cells in vitro
Cells (2.5 × 10 4 ) were seeded on 50 mm polystyrene cell culture dishes (Falcon, Corning Inc., NY). Before the measurements, medium was replaced with new pre-warmed medium to remove any debris and dead cells. Force versus indentation curves were obtained using the MFP-3D Bio AFM (Asylum Research, Santa Barbara, CA) mounted on a Zeiss Axio Observer inverted microscope (Carl Zeiss, Thornwood, NY). A V-shaped silicon nitride PNP-TR-50 cantilevers with conical indenter, actual spring constant (ĸ) of 55-246 pN nm −1 and length of 100 μm (Nano World, Switzerland) were used to measure the stiffness of cells. Deflection sensitivity of the probes was measured by taking the average of five force curves on a cell culture dish with the culture medium. The spring constant of each cantilever probe was determined using a thermal tuning method. To minimize thermal drift, cantilever was equilibrated in the culture medium for at least 45 min prior to obtaining the measurements. For determination of the elastic modulus, indentation at a scan rate of 2 μm s −1 was performed at a region just above the nucleus and an average of 5-10 force curves were recorded out of a maximum of 15 indentations per cell. For each treatment, up to 12 cells with similar morphologies were chosen for measurements. To minimize the effect of successive indentations on membrane deformation, a 3-5 s rest between each indentation point was applied. The elastic modulus (E) was extracted from force curves using the Sneddon fit (Sneddon, 1965) for a conical indenter, as shown in Equation (1),
where F is the force applied by the indenter, E is Young's modulus, ν is Poisson's ratio (assumed to be 0.5 for biological samples (Herrmann, 1965) , δ is the indentation depth and α is half angle of the indenter.
Statistical analysis
In qPCR experiments, three reactions were run for each sample, and the standard deviation (SD) was calculated. A one-way analysis of variance (ANOVA) was used to calculate significant differences among values of αSMA mRNA expression to clarify the effect of treatment, and a two-way ANOVA was used to clarify the effect of treatment and substratum stiffness. A Holm-Sidak pairwise comparison test was used for post-hoc analysis. For analysis of protein expression from the Western blotting, a one-way ANOVA was used to calculate significant differences between band densities. A one-way ANOVA was used to compare the effect of treatment on cellular stiffness as measured by AFM. Significance was defined as P < 0.05 for all analyses. Statistically significant differences are indicated in figures as *P < 0.05, **P < 0.01, ***P < 0.001 unless stated otherwise.
Results
We initially tested a range of TGFβ1 concentrations to determine the optimal dose to induce transformation of HCFs to myofibroblasts under our conditions. The addition of TGFβ1 to the culture medium for 24 h stimulated the expression of the myofibroblast marker αSMA in HCFs as previously reported (Jester and Ho-Chang, 2003) . The mRNA expression of αSMA showed a clear dose response to TGFβ1 at concentrations from 0 to 5 ng/ml, while concentrations 5-10 ng/ml did not cause a further increase (Fig. 1) . A degree of variability in the response of primary cells from different human donors is common (Oh et al., 2006; Russell et al., 2008) . To prevent data trends from being masked by Fig. 1 . Transforming growth factor-β1 increases the mRNA expression of αSMA in HCFs. Shown is a representative graph from one of at least three experiments from three donors demonstrating the relative mRNA expression of αSMA in HCFs cultured on TCP for 24 h with various concentrations of TGFβ1. A degree of variability in the response of primary cells from different human donors is common (Oh et al., 2006; Russell et al., 2008) . Results from three different donors are presented in Supplementary Tables. The pattern observed in all cases was similar. Maximal expression of αSMA was achieved at 5 ng/ml of TGFβ1. Data are mean ± SD for donor 14. * Statistically significant differences compared with the expression in cells cultured without TGFβ1 or HGF (***P < 0.001, one-way ANOVA, followed by Holm-Sidak pairwise comparison test).
averaging, we presented the result from three different donors separately in Supplementary Tables, while we Table 1 ). By contrast, the addition of HGF to the culture medium for 24 h did not significantly alter the expression of αSMA (Fig. 2 and Supplementary Table 2 ), although high HGF concentrations sporadically inhibited αSMA expression in some donors.
To investigate the effect of HGF on the induction of αSMA mRNA by TGFβ1, we treated HCFs with TGFβ1 (2 ng/ml) and a range of HGF concentrations for 24 h. The concentration of 2 ng/ml TGFβ1 was selected to allow for detection of both down regulation and upregulation of αSMA in response to the addition of HGF. Concentrations 5-50 ng/ ml of HGF suppressed the induction of αSMA by TGFβ1, with maximal inhibition observed at 20 ng/ml HGF ( Fig. 3A and Supplementary  Table 3 ). Western blot analyses were also performed using cell lysates of HCFs incubated with medium ± 5 ng/ml TGFβ1 or 20 ng/ml HGF for 24 h. We detected significant reduction of αSMA protein in HCFs incubated with TGFβ1 and HGF compared to cells cultured with TGFβ1 alone (Fig. 3B and C) .
Next, we tested the effect of HGF on the myofibroblast phenotype. We incubated HCFs with the medium containing 5 ng/ml TGFβ1 for 24 h to induce the differentiation into myofibroblasts, subsequently cells were incubated with fresh medium ± 5 ng/ml TGFβ1 or 20 ng/ml HGF for another 24 h. Cells incubated with TGFβ1 for 24 h had equivalent amounts of αSMA mRNA expression versus cells incubated with TGFβ1 for 48 h even after 24-h recovery ( Fig. 4A and Supplementary Table 4A ). The protein expression was consistent with the qPCR results, which indicated that 24-h incubation of TGFβ1 promoted transformation of HCFs to myofibroblasts ( Supplementary  Fig. 1A ). The expression of αSMA mRNA and protein was significantly decreased by HGF (Fig. 4B, Supplementary Table 4B and Supplementary Fig. 1B) , showing that HGF has the potential to revert the myofibroblast phenotype to that of fibroblasts. Transketolase, one of the corneal crystallins, was not dramatically altered in this time period. The ability of HGF to dramatically decrease the expression of αSMA was confirmed by immunocytochemistry (Fig. 4C) .
In other tissues, fibrosis increases the elastic modulus (Hinz, 2009 (Hinz, , 2012 Liu et al., 2010; van Putten et al., 2016) . Similarly, we have reported that corneal tissue undergoes alterations in compliance throughout the stromal wound healing process with strong correlations between increased elastic modulus, corneal haze formation, fibrosis and incidence of myofibroblasts observed (Raghunathan et al., 2017) . We also investigated the cellular stiffness of HCFs treated with medium ± 5 ng/ml TGFβ1 ± 20 ng/ml HGF for 24 h. Our data showed the elastic modulus of human corneal stromal cells was increased by TGFβ1, and the increase was significantly suppressed with HGF ( Fig. 5 and Supplementary Table 5) .
We previously reported the elastic modulus of different layers of the normal human cornea (Last et al., 2012) . These studies found the stiffness of normal corneal stroma to be approximately 25 kPa. We also documented that the stromal stiffness changes throughout wound healing in rabbits with wounded cornea becoming 3-fold stiffer (Raghunathan et al., 2017) . Using the rabbit data as a rational basis for projecting biomechanical changes in the human corneal stroma during wound healing, we estimated that the stiffness of wounded human cornea to achieve a value of approximately 75 kPa. We seeded HCFs on the substrates mimicking the stiffness values of normal and (projected) wounded human cornea (25 and 75 kPa) as well as TCP (> 1 GPa), and incubated cells with medium ± 5 ng/ml TGFβ1 or 20 ng/ml HGF for 24 h. The expression of αSMA was dramatically increased by TGFβ1 on all substrates (***P < 0.001 and **P < 0.01, Fig. 6 and Supplementary Table 6 ). Consistent with a previous report (Dreier et al., 2013) , substratum compliance altered the expression of αSMA with or without TGFβ1 ( ### P < 0.001 and ## P < 0.01, Fig. 6 and Supplementary Table 6 ). Specifically, softer substrates decreased the induction of αSMA mRNA in comparison to TCP. On softer substrates, treatment with HGF significantly suppressed the expression of αSMA induced by TGFβ1 as well as on TCP ( † † † P < 0.001, † † P < 0.01 and † P < 0.05, Fig. 6 and Supplementary Table 6 ). HGF inhibited αSMA expression even in absence of TGFβ1 on stiffer substrates. This inhibitory effect was accentuated in the presence of TGFβ1. The protein expression of αSMA on hydrogels was consistent with mRNA expression levels ( Supplementary Fig. 2 ).
Discussion
Keratocytes have been shown to differentiate to fibroblasts by serum using an in vitro bovine culture system (Beales et al., 1999) , and transformation of keratocytes or fibroblasts to myofibroblasts (KFM transformation) triggered by TGFβ has been reported in rabbit, bovine and murine cells Carrington et al., 2006; Singh et al., 2014) . Jester et al. described the TGFβ1-induced transformation of primary human corneal keratocytes and immortalized corneal fibroblasts to myofibroblasts in vitro . We previously reported substratum compliance modulates the expression of αSMA in human corneal stromal cells in vitro, with more compliant (softer) substrates inhibiting the transition of fibroblasts to myofibroblasts (Dreier et al., 2013 ). In the current study, we tested a range of TGFβ1 and HGF concentrations in primary HCFs from donors to determine the optimal concentrations of TGFβ1 and HGF required to modulate KFM transformation. All data showed some variability in the response because primary cells from human tissues have individual characteristics and responses (Oh et al., 2006; Russell et al., 2008) . However, αSMA mRNA expression was directly proportional to the concentration of TGFβ1, and the response curve of αSMA expression showed little variation among three donors. In the present study, 5 ng/ml of TGFβ1 was considered to be sufficient to induce maximal expression of αSMA in HCFs grown on TCP. While HGF by itself did not show dramatic effect on αSMA expression in HCFs, mRNA and protein expression induced by TGFβ1 was significantly suppressed by exposure to HGF. This result is consistent with previous reports (Dai and Liu, 2004; Shukla et al., 2009 ; Fig. 2 . Hepatocyte growth factor had little effect on the mRNA expression of αSMA in HCFs. Shown is a representative graph from one of at least three experiments from three donors demonstrating the relative mRNA expression of αSMA in HCFs cultured on TCP for 24 h with various concentrations of HGF. In one donor, inhibition of αSMA was observed at 20 and 100 ng/ml, while no inhibitory effect was observed in another donor (See Supplementary Table 2) . Data are mean ± SD for donor 14. **P < 0.01 compared with the expression in cells cultured without HGF (one-way ANOVA, followed by Holm-Sidak pairwise comparison test). Yong et al., 2016) .
Additionally, we investigated how HGF affected the myofibroblast phenotype. HGF reduced the expression of αSMA mRNA and protein in myofibroblasts promoted by 24-h incubation of TGFβ1. We also evaluated the protein expression of transketolase, one of the corneal crystallins (Sax et al., 1996 (Sax et al., , 2000 and a marker of the keratocyte phenotype. The expression was not dramatically altered by treatment with TGFβ1 or HGF. Our results indicate that HGF has the potential to induce reversal of the myofibroblast phenotype back to fibroblast phenotype likely via a TGFβ dependent mechanism, but not to the keratocyte phenotype in the time period evaluated. We note that the presence of serum in the culture media used in the reported experiments may have prevented reversion to the keratocyte phenotype. Myofibroblasts have been reported to be reversible to fibroblast phenotype under certain conditions (Ramos et al., 2010; Hecker et al., 2011; Artaud-Macari et al., 2013; Garrison et al., 2013) . Corneal myofibroblasts have also been shown to revert to the fibroblast phenotype under the influence of fibroblast growth factor with heparin in an in vitro rabbit culture system (Maltseva et al., 2001) , and corneal myofibroblasts were decreased by the bone morphogenetic proteins-7 via antagonizing TGFβ in an in vivo murine alkali injury model (Saika et al., 2005) . Recently, HGF was reported to have the potential to decrease the number of myofibroblasts in a murine corneal injury model (Mittal et al., 2016) . In this study, we showed the possibility of reversal of human corneal myofibroblast differentiation by HGF in vitro. This result suggests that HGF should be investigated as a potential therapeutic agent for the prevention/treatment of corneal fibrosis.
In recent years, our lab has focused its investigation on the impact of the biophysical attributes of the microenvironment of corneal cells on wound healing, and shown that biophysical cues represent potent modulators of KFM transformation (Myrna et al., 2009 (Myrna et al., , 2012 Pot et al., 2010; Dreier et al., 2013) . The effect of HGF on the biophysical attributes of the cornea and KFM transformation represents a promising avenue to explore to increase our understanding of compounds that may reverse unwanted fibrotic scars. TGFβ1 is known to induce myofibroblast transformation with subsequent expression of αSMA and increased intracellular actin stress fiber formation (Jester et al., 2005) . In this study, we demonstrated that the increase of cellular elastic modulus by exposure to TGFβ1 was significantly suppressed by HGF. In aggregate, these data suggest that cellular elastic modulus correlated with the expression of αSMA in our cultures and can be used as an additional phenotypic marker for myofibroblasts. In the present study, HCFs cultured on TCP showed greater expression of αSMA than cells cultured on softer substrates, which is consistent with previous reports (Dreier et al., 2013; Thomasy et al., 2018) . We also identified the inhibitory effect of HGF on αSMA expression in HCFs cultured on hydrogels mimicking normal and fibrotic human corneas. This inhibitory effect was accentuated in the presence of TGFβ1 and in cells cultured on stiffer substrates. Cellular stiffness, which is correlated with the number of actin stress fibers, parallels the stiffness of underlying substrates (Pelham and Wang, 1997; McKee et al., 2011; Thomasy et al., 2014) . Additionally, we recently documented that substratum compliance modulated elastic modulus of corneal stromal cells (Raghunathan et al., 2017) . Thus, it appears that HGF modulates the corneal stromal cell phenotype via inhibition of TGFβ and prevention of myofibroblast transformation. The use of biologically relevant substratum stiffness in the conduction of in vitro experiments gives important insights into the cellular response to drugs that may more accurately predict responses observed in vivo Dreier et al., 2013) .
Conclusions
In this study, HGF and substratum compliance modulated the differentiation of human corneal stromal cells in vitro. Corneal stromal cell differentiation plays critical role in normal wound healing as well as the development of fibrosis. Our data suggest the possibility that HGF may Fig. 3 . Hepatocyte growth factor suppresses the induction of αSMA mRNA and protein by TGFβ1 in HCFs. (A) Shown is a representative graph from one of at least three experiments from three donors demonstrating the relative mRNA expression of αSMA in HCFs cultured on TCP for 24 h with medium ± 2 ng/ml TGFβ1 and various concentrations of HGF. HGF significantly suppressed the induction of αSMA mRNA by TGFβ1 at all concentrations tested, with maximal inhibition observed at 20 ng/ml HGF. Data are mean ± SD for donor 38. (B) A representative Western blot from one experiment demonstrates the reduced expression of αSMA protein in HCFs cultured on TCP for 24 h with medium ± 5 ng/ml TGFβ1 ± 20 ng/ml HGF. HGF significantly suppressed the induction of αSMA protein by TGFβ1. (C) A densitometry analysis was performed to account for differences in the loaded protein amounts. The graph shows mean ± SD obtained from four independent experiments for donor 20. ***P < 0.001 and **P < 0.01 compared with the expression in cells cultured without TGFβ1 or HGF; † † † P < 0.001 and † P < 0.05 for cells cultured without versus with HGF (one-way ANOVA, followed by Holm-Sidak pairwise comparison test).
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